Recombinant CD55 antibody

Catalog No. ABIN5668198

This anti-CD55 antibody is a Mouse Chimeric antibody detecting CD55 in WB, IHC and ELISA. Suitable for Human.

Quick Overview for Recombinant CD55 antibody (ABIN5668198)

Target: CD55 (Complement Decay-Accelerating Factor (CD55))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Chimeric

Conjugate: This CD55 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Clone: LU30

Product Details anti-CD55 Antibody

Purpose: Anti-CD55 [LU30], Mouse IgG1, lambda

Specificity: The antibody binds to CD55 with a Kd of 13 nM.

Characteristics: Human

Purification: Protein A affinity purified

Immunogen: Human CD55.

Isotype: IgG1 lambda

Application Details

Application Notes: The antibody binds specifically to CD55, a glycophosphatidylinositol-anchored protein which acts together with CD46 and CD59 to protect cells from complement-mediated cell lysis. The antigen recognises C4b, C3 and C3b complement components, and, by blocking their catalytic activity, inhibits the formation of the membrane attack complex. CD55 is overexpressed in many tumour cell lines, thereby inhibiting complement-mediated cell lysis and increases tumour resistance to immune attacks.

Comment:

This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques.

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Target Details for CD55

Target: CD55 (Complement Decay-Accelerating Factor (CD55))

Alternative Name: CD55

Background: DAF, Complement decay-accelerating factor

UniProt: P08174

Pathways: Complement System, Regulation of Leukocyte Mediated Immunity